Investment Ratings
As per analysts rating in the last 6 months, the recommendation is to HOLD Albert David
-
Master Rating:
-
Albert David has an operating revenue of Rs. 289.47 Cr. on a trailing 12-month basis. An annual revenue de-growth of -19% needs improvement, Pre-tax margin of 11% is healthy, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 13% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Albert David Ltd Forecast
Price Estimates
Eps And Sales Estimates
Albert David Ltd Synopsis
NSE-Medical-Generic Drugs
Albert David Ltd is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 247.45 Cr. and Equity Capital is Rs. 5.71 Cr. for the Year ended 31/03/2021. Albert David Ltd. is a Public Limited Listed company incorporated on 16/11/1938 and has its registered office in the State of West Bengal, India. Company’s Corporate Identification Number(CIN) is L51109WB1938PLC009490 and registration number is 009490.-
Market Cap
INR 333.46 Cr
-
Sales
INR 289.47 Cr
-
Shares in Float
0.22 Cr
-
No of Funds
7 K
-
Yield
1.03%
-
Book Value
1.36
-
U/D Vol Ratio
1
-
LTDebt/Equity
1%
-
Alpha
-0.01
-
Beta
0.7
| Owner Name | Jun-21 | Mar-21 | Dec-20 |
|---|---|---|---|
| Promoters | 61.25% | 61.25% | 61.16% |
| Mutual Funds | 0.01% | 0.01% | 0.01% |
| Insurance Companies | 3.5% | 3.79% | 3.79% |
| Foreign Portfolio Investors | 0% | 0% | 0% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% |
| Individual Investors | 30.2% | 30.8% | 30.98% |
| Others | 5.03% | 4.14% | 4.05% |
| Name | Designation |
|---|---|
| Mr. A K Kothari | Executive Chairman |
| Dr. T S Parmar | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Director |
| Mr. Hemal Kampani | Director |
| Mr. Rajiv Singhi | Director |
| Mr. Arindam Sarkar | Director |
| Mr. Shirish G Belapure | Director |
| Dr. Monjori Mitra | Director |
Albert David Ltd Financials
- Quarterly P&L
- Annual P&L
- Cash Flow
- Balance Sheet
- Ratios
| INDICATOR | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 86.3389 | 81.1008 | 56.7382 | 65.2926 | 71.6876 |
| Operating Expenses Qtr Cr | 73.1619 | 70.7588 | 50.1441 | 59.5824 | 60.4642 |
| Operating Profit Qtr Cr | 13.177 | 10.342 | 6.5941 | 5.7102 | 11.2234 |
| Depreciation Qtr Cr | 2.1078 | 1.9955 | 2.0516 | 2.0799 | 2.07 |
| Interest Qtr Cr | 0.1101 | 0.148 | 0.1738 | 0.1724 | 0.141 |
| Tax Qtr Cr | 3.7375 | 2.8011 | 1.56 | 2.2285 | 2.2492 |
| Net Profit Qtr Cr | 12.6724 | 10.4454 | 7.2922 | 6.1194 | 9.793 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Total Revenue Annual Cr | 264.6298 | 327.9059 | 323.6764 | 296.3621 | 302.947 |
| Operating Expenses Annual Cr | 228.3015 | 290.4807 | 287.2298 | 265.7284 | 267.4575 |
| Operating Profit Annual in Cr | 19.1484 | 30.3143 | 29.6612 | 21.7254 | 27.8646 |
| Depreciation Cr | 8.2315 | 7.6747 | 6.978 | 8.231 | 7.5166 |
| Interest Annual Cr | 0.6532 | 0.7961 | 0.6174 | 0.8588 | 0.7375 |
| Tax Annual Cr | 5.3006 | 9.7858 | 11.1269 | 8.0617 | 10.1737 |
| Net Profit Annual Cr | 22.143 | 19.1686 | 26.6399 | 9.8408 | 15.9551 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Cash from Operating Activity Annual Cr | 36.6107 | 30.0934 | 31.9611 | 30.013 | 19.8666 |
| Cash from Investing Activity Annual Cr | -36.6844 | -19.9989 | -19.159 | -11.0346 | -36.5998 |
| Cash from Financing Annual Activity Cr | -1.705 | -10.1699 | -17.0879 | -4.5583 | 6.6913 |
| Net Cash Flow Annual Cr | -1.7787 | -0.0754 | -4.2858 | 14.4201 | -10.0419 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Total ShareHolders Funds Annual Cr | 244.382 | 222.7979 | 210.4457 | 185.9466 | 183.013 |
| Fixed Assets Annual Cr | 84.7138 | 92.5176 | 82.1438 | 88.0892 | 95.4281 |
| Total Non Current Assets Annual Cr | 117.7215 | 119.3178 | 109.055 | 117.2211 | 120.5837 |
| Total Current Assets Annual Cr | 223.6804 | 200.899 | 186.335 | 171.962 | 163.9451 |
| Total Assets Annual Cr | 341.4019 | 320.2168 | 295.39 | 289.1831 | 284.5288 |
| INDICATOR | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|
| Book Value Per Share Annual Rs | 428.199 | 390.38 | 368.737 | 325.81 | 320.67 |
| ROE Annual % | 9.06 | 8.6 | 12.65 | 5.29 | 8.71 |
| ROCE Annual % | 10.77 | 12.43 | 13.02 | 11.17 | 14.23 |
| Total Debt to Total Equity Annual | - | - | - | - | - |
| EBDIT Annual Margin % | 14.68 | 11.66 | 11.5 | 10.65 | 12.01 |
Albert David Ltd Technicals
EMA & SMA
CURRENT PRICE
584.3 
(0.71)
-
- Bullish Moving Averages 7
- Bearish Moving Averages 9
EMA
-
20 Day
593.79
-
50 Day
593.02
-
100 Day
571.3
-
200 Day
510.98
Albert David Ltd Resistance and support
581.21 PIVOT
-
First Resistance
587.05
-
Second Resistance
593.9
-
Third Resistance
599.75
-
First Support
574.35
-
Second Support
568.5
-
Third Support
561.65
-
RSI
44
-
MFI
67.35
-
MACD
-5.08
-
MACD signal line
-2.1
Albert David Ltd Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 11,227 | 438,414 | 39.05% |
| Week | 19,058 | 910,763 | 47.79% |
| 1 Month | 18,160 | 1,082,684 | 59.62% |
| 6 Month | 61,097 | 2,278,903 | 37.3% |
Albert David Ltd Price change analysis
-15.25
Over 1 month
Low High 568.6 658.75
15.3
Over 3 month
Low High 559.95 658.75
116.8
Over 6 months
Low High 455.1 673.8
125.1
Over Year
Low High 371.45 673.8Similar Stocks
| Company Name | 52 Week () |
Market Price () | Volume |
|---|---|---|---|
| Orchid Pharma Ltd | 2,680.00 | 402.90 (0.22%) | 1735 |
| Suven Life Sciences Ltd | 124.40 | 91.30 (2.35%) | 23877 |
| Panacea Biotec Ltd | 453.70 | 225.75 (5.00%) | 36430 |
| Medicamen Biotech Ltd | 772.00 | 600.00 (0.99%) | 758 |
News
Albert David Ltd - 524075 - Compliances-Reg. 39 (3) - Detail
Issue of duplicate share certificates pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, Read More
ALBERT DAVID LTD.-$ - 524075 - Announcement under Regulation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we enclos Read More
Albert David Ltd - 524075 - Compliances-Reg. 39 (3) - Detail
Intimation of Loss of Certificate/Duplicate Certificate Read More
ALBERT DAVID LTD.-$ - 524075 - Results - September 30, 2021
This has reference to our letter dated November 2, 2021. In compliance with Regulation 33 of the Listing Regulations, enclosed please find t Read More
ALBERT DAVID LTD.-$ - 524075 - Board Meeting Outcome for Out
This has reference to our letter dated November 2, 2021. In compliance with Regulation 33 of the Listing Regulations, enclosed please find t Read MoreBlogs